Bionomics Limited Stock Total Debt
Bionomics Limited fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Pink Sheet. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics pink sheet.
Bionomics |
Bionomics Limited Company Total Debt Analysis
Bionomics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Bionomics Total Debt | 693.62 K |
Most of Bionomics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Bionomics Limited has a Total Debt of 693.62 K. This is 99.97% lower than that of the Healthcare sector and 99.79% lower than that of the Biotechnology industry. The total debt for all United States stocks is 99.99% higher than that of the company.
Bionomics Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionomics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics of similar companies.Bionomics is currently under evaluation in total debt category among its peers.
Bionomics Fundamentals
| Return On Equity | -0.42 | |||
| Return On Asset | -0.18 | |||
| Operating Margin | (2.91) % | |||
| Current Valuation | 27.83 M | |||
| Shares Outstanding | 1.35 B | |||
| Shares Owned By Insiders | 6.00 % | |||
| Shares Owned By Institutions | 48.96 % | |||
| Price To Earning | (34.09) X | |||
| Price To Book | 1.24 X | |||
| Price To Sales | 8.29 X | |||
| Revenue | 263.63 K | |||
| Gross Profit | (9.94 M) | |||
| EBITDA | (21.92 M) | |||
| Net Income | (21.76 M) | |||
| Cash And Equivalents | 33.56 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 693.62 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 12.46 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (21.76 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 22 | |||
| Beta | 2.18 | |||
| Market Capitalization | 29.11 M | |||
| Total Asset | 65.31 M | |||
| Retained Earnings | (103 M) | |||
| Working Capital | 47 M | |||
| Current Asset | 58 M | |||
| Current Liabilities | 11 M | |||
| Z Score | 23.2 | |||
| Net Asset | 65.31 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |